Bi-level vs. Single Level ESB in VATS
The Analgesic Efficacy of Bi-level Versus Single Level Erector Spinae Block in Video Assisted Thoracoscopic Surgery: a Randomized Patient Blinded Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Cheng Lin
- Phone Number: 5197025758
- Email: cheng.lin@lhsc.on.ca
Study Locations
-
-
Ontario
-
London, Ontario, Canada, n6c6a7
- Cheng Lin
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- adult patients (at least 18 years old)
- elective unilateral wedge resection, segmentectomy, lobectomy or bilobectomy via VATS
Exclusion Criteria:
- history of malignant hyperthermia
- BMI > 40, chronic pain condition
- Daily opioid consumption of more than 60 mg oral morphine equivalents
- Conversion to thoracotomy
- Insertion of epidural
- postoperative admission to ICU
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Single level block arm - Control
Single level erector spinae block at 4th transverse process
|
erector spinae block at 4th transverse process
|
|
Experimental: Bi-level block arm - Intervention
Bi-level erector spinae block at 4th and 6th transverse process
|
erector spinae block at 4th and 6th transverse process
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Opioid use in first 12 postoperaive hour
Time Frame: First 12 hour from arriving at postoperative recovery
|
First 12 hour from arriving at postoperative recovery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain score area under curve first 12 hour
Time Frame: First 12 hour from arriving at postoperative recovery
|
Numeric rating scale, 0 to 10, 0 being no pain and 10 being the worst possible pain
|
First 12 hour from arriving at postoperative recovery
|
|
Pain score area under curve first 24 hour
Time Frame: First 24 hour from arriving at postoperative recovery
|
Numeric rating scale, 0 to 10, 0 being no pain and 10 being the worst possible pain
|
First 24 hour from arriving at postoperative recovery
|
|
Incidence of Acute block complication - based on clinical assessment
Time Frame: First 12 hour since block placement
|
pneumothorax, local anesthetic toxicity, epidural spread, bleeding
|
First 12 hour since block placement
|
|
Incidence of Delayed block complication - based on clinical assessment
Time Frame: First 5 days
|
paresthesia, motor weakness, hematoma, abscess
|
First 5 days
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 120374
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.